Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Rectal Artery Embolization.
- Кому может быть актуально
- Состояния в реестре: Internal Hemorrhoid. Базовые параметры: 18 лет — 90 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Hemorrhoidal Embolization Trial-1 (HEMBO-1)
Обзор
This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
Подробное описание
This is a prospective, single-arm, single center phase I/IIa observational study to systematically investigate outcomes and quality of life in patients with grade II or III bleeding predominant internal hemorrhoids referred to Vascular and Interventional Radiology (VIR) by Colorectal Surgery (CRS) for clinically indicated rectal artery embolization. 20 adult patients who meet the inclusion and exclusion criteria will be consented and enrolled in the study.
During the study, the subject will undergo 6 study visits, one before and five after their clinical rectal artery embolization procedure. Patients referred from the Colorectal Surgery Clinic who are scheduled to undergo rectal artery embolization (RAE) as part of standard clinical care will be enrolled. Baseline anoscopy and clinical evaluation will be performed per standard clinical care in the Colorectal Surgery Clinic and baseline patient reported outcomes and quality of life questionnaires administered. A research pelvis CTA will be performed on a clinical CT scanner per standard clinical imaging protocol for assessment of the rectal arteries prior to embolization. Following rectal artery embolization, subjects will undergo a day 1 post-procedure clinical evaluation in Interventional Radiology followed by repeat anoscopy and clinical evaluation per standard clinical care in the Colorectal Surgery Clinic as well as repeat patient reported outcomes and quality of life questionnaires at 1, 3, 6 and 12 months post rectal artery embolization with a clinical research study coordinator in Vascular and Interventional Radiology, either in person or virtually (video or phone).
The aims of the study are:
Aim 1. To determine the 12-month efficacy of rectal artery embolization with particles + coils for treatment of symptomatic bleeding predominant hemorrhoidal disease
Aim 2. To determine the 12-month safety of rectal artery embolization with particles + coils for treatment of symptomatic bleeding predominant hemorrhoidal disease.
Aim 3. To determine the feasibility of pre-embolization CTA in identifying the hemorrhoidal arteries supplying the hemorrhoidal cushion
Вмешательства
- Устройство Rectal Artery Embolization
Subjects will undergo planned rectal artery embolization (RAE) in Vascular and Interventional Radiology per standard clinical protocol.
Первичные конечные точки
- Change in French bleeding score (FBS) [Срок оценки: Baseline, 1, 3, 6 and 12 months]
- Adverse Events [Срок оценки: Day 1 and 1, 3, 6 and 12 months]
- Diagnostic accuracy of pre-embolization Computed Tomography Angiography (CTA) [Срок оценки: Baseline (pre-embolization)]
Вторичные конечные точки (7)
- Visual Analog Scale (VSS) Pain [Срок оценки: Baseline, 1, 3, 6 and 12 months]
- Visual Analog Scale (VAS) for Quality of Life [Срок оценки: Baseline, 1, 3, 6 and 12 months]
- Goligher Prolapse Score [Срок оценки: Baseline, 1, 3, 6 and 12 months]
- Hemorrhoidal Bleeding Score (HBS) [Срок оценки: Baseline, 1, 3, 6 and 12 months]
- Hemorrhoidal Severity Score (HSS) [Срок оценки: Baseline, 1, 3, 6 and 12 months]
- Vaizey Incontinence Score [Срок оценки: Baseline, 1, 3, 6 and 12 months]
- Brief Pain Inventory (BPI) Short Form [Срок оценки: Baseline, 1, 3, 6 and 12 months]
Критерии участия
Критерии включения
- Grade II or III hemorrhoidal disease as determined by a board-certified colorectal surgeon.
- Persistent or recurrent symptoms following hygiene and dietary measures or medication.
- Bleeding predominant ± pain symptoms.
- Undergoing planned rectal artery embolization (RAE) per standard clinical care.
- Male or female with age greater than 18 years, with the capacity and willingness to provide a written informed consent.
- Negative pregnancy test (if applicable).
Критерии исключения
- Prior hemorrhoid surgery.
- Grade IV hemorrhoidal disease.
- Acute hemorrhoid complications.
- Chronic anal or perianal fissures.
- History of colorectal surgery or pelvic radiation.
- Inflammatory bowel disease.
- Portal hypertension or mesenteric venous congestion/occlusion.
- Inferior mesenteric artery (IMA) or internal iliac artery (IIA) stenosis or occlusion.
- Contraindication to iodinated contrast.
- Pregnant and/or breast-feeding subjects. A negative pregnancy test within 48 hours of the procedure per clinical care.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
США · 1 центр
- Mayo Clinic Minnesota — Rochester
Идентификаторы
NCT: NCT06106269 · 23-002845